Table 3.
Univariate and Multivariate analyses of the overall survival of the 246 gastric cancer patients
Variables | Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|---|
| |||||
No. | P valuea | Hazard Ratio | 95% CI | P valuea | |
Per1 | < 0.001 | 1.245 | 0.887-1.747 | 0.205 | |
Low expression | 143 | ||||
High expression | 103 | ||||
Per2 | 0.002 | 1.462 | 1.053-2.031 | 0.023 | |
Low expression | 160 | ||||
High expression | 86 | ||||
Gender | 0.177 | ||||
Female | 65 | ||||
Male | 181 | ||||
Size (cm) | 0.001 | 1.318 | 0.971-1.789 | 0.076 | |
≤ 5.0 | 154 | ||||
> 5.0 | 92 | ||||
Age (years) | 0.598 | ||||
≤ 60 | 131 | ||||
> 60 | 115 | ||||
Depth of invasion | < 0.001 | 2.581 | 1.219-5.464 | 0.013 | |
T1 + T2 | 48 | ||||
T3 + T4 | 198 | ||||
Lymph node metastasis | < 0.001 | 2.419 | 1.054-5.552 | 0.037 | |
Negative | 52 | ||||
Positive | 194 | ||||
Clinical Stage | < 0.001 | 1.078 | 0.433-2.685 | 0.871 | |
I + II | 63 | ||||
III + IV | 183 | ||||
Location | < 0.001 | 0.762 | 0.563-1.032 | 0.079 | |
Upper | 108 | ||||
Middle/lower | 138 | ||||
pathologic differentiation | 0.029 | 0.983 | 0.688-1.406 | 0.925 | |
Well + Moderate differentiation adenocarcinoma | 71 | ||||
Poor differentiation adenocarcinoma | 175 |
CI, confidence interval.
p value < 0.05.